The influence of leprosy-related clinical and epidemiological variables in the occurrence and severity of COVID-19: A prospective real-world cohort study.

Selma Regina Penha Silva CerqueiraPatrícia Duarte DepsDébora Vilela CunhaNatanael Victor Furtunato BezerraDaniel Holanda Barroso Ana Bárbara Sapienza Pinheiro Gecilmara Cristina Salviato Pileggi Taynah Alves Rocha Repsold Patricia Shu Kurizky Simon Michael Collin Ciro Martins Gomes

Published in: PLoS neglected tropical diseases (2021)

Leprosy patients are vulnerable to COVID-19 because they have more frequent contact with SARS-CoV-2-infected patients, possibly due to social and economic limitations. Our model showed that the use of corticosteroids, thalidomide, pentoxifylline, clofazimine, or dapsone or BCG vaccination did not affect the occurrence or severity of COVID-19.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
end stage renal disease
risk assessment
chronic kidney disease
ejection fraction
newly diagnosed
healthcare
peritoneal dialysis
patient reported